| |
|
|
|
Anavex Life Sciences Corp.  
|
|
2.59 0.02 (0.01%) |
02-15 16:00 |
|
Open: |
2.58 |
Pre close: |
2.57 |
Target:
|
3.13 
|
|
High: |
2.6799 |
Low: |
2.565 |
Resistance:
|
2.68
3.13
|
|
Volume: |
254,596 |
Market Cap: |
121M |
Support:
|
2.08
1.71
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.50
|
MACD |
MACD(12,26):
|
0.17 |
|
MA(20): |
2.07 |
Signal(12,26,9): |
0.10 |
|
MA(100): |
2.21 |
Stochastic Oscillator |
%K(14,3):
|
89.14  |
|
MA(250): |
2.55 |
%D(3): |
89.18 |
|
Average Volume(K) |
3-Month: |
24168
|
52-Week |
High:
|
4.35 |
|
10-Days: |
25251 |
Low: |
1.25 |
|
RSI |
RSI(14):
|
75.11 |
Change(%): |
0.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.390 |
Return on Equity (ttm) |
-78.4 |
Shares Out. (M) |
46.89 |
|
EPS Est. Current Year |
-0.370 |
Return on Assets (ttm) |
-67.2 |
Shares Float (M) |
36.75 |
|
EPS Est. Next Year |
-0.450 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
22.00 |
|
Forward EPS |
-0.480 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
4.810 |
EBITDA (p.s.) |
0.000 |
P/E |
-6.64 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.54 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-12.58 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-6.31 |
P/CF |
-9.65 |
|
|
|
|
|
|
